Peptidoglycan (PG)-polysaccharide (PS) polymers derived from group A streptococcal cell walls were solubilized by M-1 mutanolysin (endo-N-acetylmuramidase) and phage-associated lysin (N-acetylmuramyl-L-alanine amidase). Fragments were isolated by ultrafiltration and a series of gel filtrations and were injected intravenously into Sprague-Dawley rats. No fragments with a molecular weight of less than 5 x 106 were able to induce arthritis by systemic injection. However, the enzyme-derived fragments displayed a new biological activity. High-molecular-weight PG-PS fragments (-500,000) derived from mutanolysin digests induced a severe edematous reaction in the front and hind limbs. The response started 5 to 10 min postinjection, reached maximum intensity in approximately 30 min, and disappeared by 10 h. The smallest dose capable of eliciting the response was 0.31 ,ug/g of body weight. Low-molecular-weight PG-PS (-30,000) derived from the mutanolysin digests and the PG-PS fragments isolated from phage-associated lysin digests also induced edema; however, a higher dose was required to elicit the same response as that produced by high-molecularweight PG-PS fragments. The active fragments contained rhamnose, glucosamine, muramic acid, alanine, glutamic acid, and lysine in various molar ratios. PG-PS fragments obtained by sonic degradation of cell walls (molecular weight ¢5.3 x 106), as well as enzyme-treated PG preparations and muramyl dipeptide, failed to elicit the response. These findings indicate that PG-PS fragments of sizes too small to be arthritogenic can affect the vascular endothelium to induce a rapidly developing edema. Fragments with this biological property could have a key role in the pathogenesis of experimental arthritis by influencing the tissue distribution of arthritogenic PG-PS.
A single injection of an aqueous suspension of group A streptococcal cell wall produces chronic, remittent inflammation in joints, heart, intestines, or skin; the location of lesions depends on the species of animal and the route of injection (4, 5, 20, 21, 24, 25) . In each of the experimental models, the essential cell wall structure is the peptidoglycan (PG)-polysaccharide (PS) complex. The arthritis produced in rats by intraperitoneal injection of PG-PS is clinically, histologically, and radiologically similar to human rheumatoid arthritis (3, 5) . Recently, we reported that the size of PG-PS fragments obtained by sonic degradation of cell wall plays an important role in determining the relative severity of the early and late phases of arthritis in the rat model (10). The smallest fragments (molecular weight The finding that the size of PG-PS fragments plays an important role in the arthropathogenicity of the cell wall prompted us to utilize cell wall-lytic enzymes to generate a greater spectrum of size and structural modification of the PG-PS fragments to relate more precisely biological activity and structure. The cell wall-lytic enzymes utilized in these studies included mutanolysin (27, 28) and group C streptococcal phage-associated lysin (8, 9, 15) . This report describes methods of isolation and characterization of the PG-PS fragments generated by these enzymes and the biological properties of these fragments.
MATERIALS AND METHODS
Preparation of cell wall. Purified cell walls were prepared from group A, type 3, strain D58 streptococci as previously described (10). In brief, the cells were EDEMA INDUCED BY SOLUBLE CELL WALL FRAGMENTS 1011 phosphate, 0.15 M NaCI [pH 7.2]). Washed cells were disrupted in a Braun MSK shaker, and the cell walls were collected by differential centrifugation (10,000 x g for 30 min at 4°C) and further purified by sequential RNase, trypsin, and papain treatments and by chloroform-methanol extraction. The purified cell walls, which consisted primarily of PG-PS complexes, were extracted with formamide (16) to obtain PG preparations. In addition, PG preparations were prepared from streptococcal group A-variant strain K43.
Cell wall-lytic enzymes. The M-1 fraction of mutanolysin (an endo-N-acetylmuramidase) was obtained from K. Yokogawa Method of scoring acute nflammation. Rats in groups offour or five were injected intravenously (i.v.) with 0.2 to 0.4 ml of the fractions or preparations to be tested. In all of the experiments, the fractions or preparations were dissolved in and diluted with sterile PBS. Negative control groups were injected with PBS, and the endotoxin control groups were injected with solutions of Salmonella typhimurium lipopolysaccharide (Difco Laboratories, Detroit, Mich.). A positive response was indicated by the appearance of edema in the front and hind limbs within 30 min postinjection. The intensity of edema of each limb was estimated by using an arbitrary 0 to 4 scale; therefore, the maximum total score that a rat could receive was 16.
The accuracy and precision of scoring was determined by comparing the clinical assessment of swelling with the amount of ['25 (1.15 X 10-3 RCi/g of body weight); 30 min later, the rats were injected in the left joint with 10 ,ul of PBS and in the right joint with 10 R1 of a PG-PS peparation. Thirty minutes after intraarticular injection, the rats were scored for edema and immediately anesthesized with ether, the heart blood was collected, and the left and the right limbs were removed. The amount of ['25 ]HSA in the left and right limbs and in the blood was determined with a gamma counter (1197 series Automatic Gamma Counting System; Searle Analytic Inc., Des Plaines, 11.).
Preparation of active cell wall fragments (PG-PS) by enzyme treatments. Purified cell wall (500 mg) was suspended to a concentration of 1 mg/ml in acetate buffer (0.05 M sodium acetate [pH 5.5]) containing 0.5 mM MgCI2 and 0.05% NaN3. Mutanolysin (5.0 mg in 5 ml of acetate buffer) was added to the cell wall suspension, and the mixture was incubated, with periodic mixing, at 37°C for % h. Samples were taken from the incubation mixture at various times for optical density measurements (A = 600 nm) and for reducing sugar determinations (26) . At the end of the incubation period, the mixture was centrifuged at 10,000 x g at 4°C for 30 min to remove residual unsolubilized cell walls. Cell wall fragments in the supernatant were resolved into two major groups, high-molecularweight (HMW) PG-PS fragments and low-molecularweight (LMW) PG-PS fragments, by filtration through a PM 10 membrane (Amicon Corp., Lexington, Mass.) (Fig. 1) .
The HMW PG-PS fragments (PM 10 retentate) were dialyzed against distilled water to remove salts and NaN3 and lyophilized. The lyophilized preparation was dissolved in 10 ml of 0.01 M Tris-hydrochloride buffer (pH 7.4) and applied to a 2.6-by 95-cm column of Sepharose 6B equilibrated at 4°C with Tris-hydrochloride buffer and eluted at a flow rate of 18 ml/h. Fractions of 4.5 ml were collected and assayed for absorbance at 220 nm (A220) and for rhamnose (7) . The fractions which contained A220-absorbing materials or rhamnose or both were tested for edema-producing activity, and the active fra lyophilized.
The LMW PG-PS fragme concentrated and washed wi a stirred cell equipped with brane and lyophilized. The was dissolved in 5 ml of Tris-hydrochloride buffer, applied to a 2.6-by 92.5-cm column of Sephadex G-100 equilibrated at 4°C with Tris-hydrochloride buffer, and */ . eluted at a flow rate of 20 ml/h. Fractions of 5 ml were collected and assayed for A220, rhamnose, and edema-./ producing activity as described above. Edema-producing PG-PS fragments were also ob-/s .tained by treatment of the purified cell wall with group C streptococcal phage-associated lysin. Purified cell r=0.97 wall (500 mg) was added to 300 ml of the activated P < 0.001 lysin and incubated at 37°C for 24 h. The cell wall-lysin mixture was centrifuged at 10,000 x g at 4°C for 30 min to remove insoluble materials. Solubilized cell wall fragments in the supernatant were concentrated to 25 ' ' ' ' ' ml by ultrafiltration in a stirred cell equipped with a 5 6 7 8 9 10 PM 10 membrane and dialyzed against distilled water before lyophilization. The lyophilized preparation was LIMB (cpm x 103) suspended in 10 ml of Tris-hydrochloride buffer and nical assessment of swell-applied to the previously mentioned Sepharose 6B tion. Each dot represents column. the mutanolysin-derived Preparation of PG fragments by enzyme treatment. )ns ranging from 0.1 to 50 Isolated PG preparation (100 mg) was suspended in 20 f the limbs injected with ml of PBS and incubated with 1 Preparation of PG-PS fragments by sonic treatment. Lyophilized purified cell walls were sonicated for 70 min in a Branson sonifier, and the 100S60 and the 100P60 fractions were isolated from the cell wall sonicates as previously described (10). The PG-PS fragments in the 100S60 fraction were applied to the previously mentioned column of Sepharose 6B and eluted with Tris-hydrochloride buffer. The fragments eluted in the void volume fractions of the column were pooled, dialyzed against deionized distilled water, and lyophilized. The MW of these fragments was approximately 5.3 x 106 (10).
Chemical analyses. Muramic acid, glucosamine, and glucose were assayed as their alditol acetates by gasliquid chromatography (23 
RESULTS
Acute inflammation induced by PG-PS fragments. Preliminary experiments (Fig. 2) indicated an excellent correlation between clinical scoring of edematous swelling and [125I]HSA accumulation in the limbs (r = 0.97; P < 0.001). Therefore, the clinical assessment of swelling was used in the present studies. Within 5 to 10 min after i.v. injection of PG-PS fragments, erythema appeared in both front and hind limbs, followed by edematous swelling (Fig. 3) . Depending on the dose injected, the edematous response of the limbs usually was maximum by 30 min postinjection, began to disappear by 1 h, and was undetectable by 10 h (Fig. 4) . The time course of edema induced by other PG-PS fragments was similar to that of HMW PG-PS. Occasionally, swelling also appeared around the nose but not in the ears or tail. None of the enzyme-derived PG-PS fragments was capable of inducing chronic erosive arthritis, even when injected at 26 jxg/g of body weight; however, at this dose, the mutanolysin-derived HMW PG-PS and the phage-associated lysin-derived PG-PS induced cyanosis within 2 min. This cyanosis lasted for approximately 15 min and was followed by the appearance of erythema and edema, which persisted for 12 h in all extremities. Occasionally, with this high dose, one or two of five rats died within 30 min. b This PG preparation contained 4.0% (wt/wt) rhamnose, indicating the presence of a small amount of covalently bound polysaccharide.
c Rhamnose was not detectable in this PG preparation.
d The amounts used reflected the concentration of these enzymes in the incubation mixtures.
Isolation and characterization of edema-producing PG-PS fragments. Treatment of the purified cell walls with mutanolysin resulted in a decrease in optical density and an increase in reducing groups in the supernatant fluid. After 96 h, the resulting PG-PS fragments were very heterogeneous in size. The fragments were resolved by ultrafiltration into two major groups, the HMW PG-PS and the LMW PG-PS. The yield of the HMW PG-PS was approximately 15% of the starting cell walls and was much higher than the yield of the LMW PG-PS (1.5%). Both PG-PS preparations induced the edematous response in rats ( Table 1) .
The elution profile of the Sepharose 6B gel filtration of the PM 10 retentate of the cell wall digests showed that the HMW PG-PS fragments were eluted in the major peak, which had a Kay of 0.38 (Fig. 5) . The weight average MW of the fragments in this peak was approximately 500,000, as determined by light scattering. The minimum amount of these PG-PS fragments capable of inducing edema was approximately 0.31 ,ug/g of body weight ( Table 1 ). The small peak of PG-PS fragments which was eluted in the void volume did not contain detectable edema-producing activity when a dose of 3.3 ,ug/g of body weight was tested.
The elution profile of the Sephadex G-100 gel filtration of the PM 10 filtrate of the cell wall digests is shown in Fig. 6 ELUTION VOLUME (ml) FIG. 7 . Elution profile of a Sepharose 6B gel filtration of PG-PS fragments generated by group C streptococcal phage-associated lysin. A sample (5 mg in 4 ml of Tris-hydrochloride) was applied to the Sepharose column (4°C) and eluted as described in the legend to Fig. 5 . 0, Absorbance at 220 nm; *, rhamnose. The active fractions are indicated. VO, Void volume; Vt, total bed volume. streptococcal phage-associated lysin also yielded PG-PS fragments which were capable of inducing edema. The elution profile of the Sepharose 6B gel filtration of the cell wall digests indicated that the active PG-PS fragments were eluted in the major peak, which had a Kay of 0.44 (Fig. 7) . Based on this Ka, value, the average size of the PG-PS fragments should be similar to or slightly smaller than the HMW PG-PS fragments derived from the treatment of cell walls with mutanolysin. In addition, the time course of edema induced by these PG-PS fragments was similar to that of the mutanolysin-derived HMW PG-PS. The smallest amount of these fragments capable of inducing edema was approximately 1.25 p.g/g of body weight (Table 1) , and the yield of the fragments was approximately 12% of the starting cell wall preparation.
Isolation of PG fragments. The PG prepared from group A, strain D58 streptococcal cell walls still contained approximately 4.7% rhamnose, even after six successive extractions with formamide, whereas the PG preparation prepared from the group A-variant strain K43 streptococcal cell walls contained less than 1% rhamnose after a similar treatment with formamide.
Both PG preparations were highly susceptible to mutanolysin, and a complete clearing of the incubation mixture occurred within 60 min (determined by optical density at 254 nm). The elution profiles of Sephadex G-25 gel filtration of the group A D58 PG lysates (Fig. 8A ) and the group A-variant strain K43 PG lysates (Fig. 8B) indicated that the majority of PG fragments were excluded by the gel. The materials in the excluded peak derived from group A D58 PG contained significant amounts of rhamnose. This finding suggested the presence of PG-PS fragments. Analysis of these PG-PS fragments by gel filtration indicated that they had sizes similar to those of mutanolysin-derived LMW PG-PS fragments (data not shown). On the other hand, the PG fragments derived from K43 PG did not contain detectable amounts of rhamnose. Thus, only rhamnose-containing fractions of PG induced an edematous response, and a higher dose of such fractions was required to elicit responses comparable to those seen with other PG-PS fragments (Table 1) .
Chemical analyses. The similarities in the molar ratios of muramic acid, alanine, and glutamic acid to lysine in the active edema-producing PG-PS fragments (Table 2) suggested that the fragments contained similar PG components. On the other hand, the amounts of covalently bound PS were different, as indicated by the differences in the molar ratios of rhamnose and glucosamine to lysine. The edema-producing PG-PS fragments were free of other sugars and amino sugars and contained less than 1.0% (wt/wt) non-PG-associated amino acids. ELUTION VOLUME (ml) Other studies relating the size and fine structure of the streptococcal group A cell wall to its biological activities include the findings that the PG-PS fragments obtained from the treatment of group A streptococcal cell wall with L-11 enzyme (Kyowa lytic no. 2) (12) possessed pyrogenic activity in rabbits (13) and that the fragments induced cardiac lesions in mice (18) . However, it is not known whether the products of the L-11 enzyme (in aqueous suspension) are capable of inducing arthritis (5) or edema as described in this report. Cell walls isolated from several bacterial species, including Streptococcus pyogenes, as well as MDP and some of the 6-O-acyl derivatives of MDP, induced contraction of guinea pig ileal strips (19) . In addition, Ohkuni and Kimura (22) have shown that the PG fraction extracted from group A streptococcal cell walls can cause increased capillary permeability of the skin of guinea pigs and rats when it is injected intracutaneously. Their results cannot be directly compared with ours because of the differences in the routes of injection.
The results of chemical analyses of various edema-producing PG-PS fragments (Table 2) indicated that all fragments contained similar PG components. However, the mutanolysin-derived HMW PG-PS and the phage-associated lysinderived PG-PS fragments contained larger poly- mers of the covalently bound PS than did LMW PG-PS. The differences in the molar ratios of rhamnose and glucosamine to lysine in these PG-PS fragments suggest heterogeneity of the length of PS polymers. Recently, the heterogeneity of the group A streptococcal PS was demonstrated by immunochemical analysis (11) , and the authors suggested that the heterogeneity may have resulted from attachment of various amounts of N-acetylglucosamine to the polyrhamnose backbone. Under the conditions used in the present studies, we observed that the mutanolysin-derived LMW PG-PS and the PG-PS fragments obtained from the formamideextracted cell walls were less active in eliciting the edematous response than were those of the mutanolysin-derived HMW PG-PS (Table 1) . It is not known whether this resulted from the differences in their sizes or from the differences in the length of the covalently bound rhamnose oligosaccharides. Experiments are in progress in our laboratory to determine the active moiety of the edemaproducing PG-PS fragments. The findings that all of the active fragments contained a PS moiety and that the severity of edema was related to the size of the PS polymers suggest that PS is the active moiety. Furthermore, the absence of edema-producing activity in the PG fragments which were derived from the group A-variant (K43) PG preparation and which did not contain detectable amounts of rhamnose supports the idea that PS is essential for the activity. If so, this is the first documented report of biological activity of a group-specific polysaccharide.
Our working hypothesis is that this early edematous response reflects an effect of soluble PG-PS fragments on vascular endothelium of the synovial tissue. This might be important as an initial step in the pathogenesis of experimental arthritis induced by systemic injection of streptococcal cell walls. The edema-producing PG-PS fragments are present in small concentrations in the cell wall sonicate which is used to induce the experimental arthritis (data not shown). In addition, it is possible that edema-producing PG-PS fragments could be generated from the largersize cell walls through an in vivo degradation process. In any case, the edema-producing PG-PS fragments cause an initial increase in vascular permeability which may facilitate localization of the larger arthritogenic fragments in the joint. LITERATURE CITED
